MCH ADVISORY RESEARCHMain site ↗
Materials

Specialty Chemicals

13 companies under coverage.

Coverage

Specialty Chemicals


Equity Research

Albemarle Corp (ALB)

HOLD. 12-month probability-weighted target $141 (+8% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.8%
Equity Research

PPG Industries Inc (PPG)

HOLD. 12-month probability-weighted target $118 (+7% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PPGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.2%
Equity Research

Dupont De Nemours Inc (DD)

HOLD. 12-month probability-weighted target $135 (+3% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

DDEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.7%
Equity Research

Sherwin-Williams Co (SHW)

HOLD. 12-month probability-weighted target $336 (+3% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

SHWEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.1%
Equity Research

RPM International Inc (RPM)

HOLD. 12-month probability-weighted target $103 (+1% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

RPMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.6%
Equity Research

Ecolab Inc (ECL)

HOLD. 12-month probability-weighted target $277 (+0% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ECLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -15.5%
Equity Research

Axalta Coating Systems Ltd (AXTA)

HOLD. 12-month probability-weighted target $36 (+2% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AXTAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -16.0%
Equity Research

Avient Corp (AVNT)

HOLD. 12-month probability-weighted target $42 (+0% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

AVNTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -20.6%
Equity Research

NewMarket Corporation (NEU)

SELL. 12-month probability-weighted target $796 (-8% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

NEUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -20.7%
Equity Research

Westlake Chemical Corporation (WLK)

HOLD. 12-month probability-weighted target $78 (+4% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

WLKEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -23.9%
Equity Research

Solstice Advanced Materials, Inc (SOLS)

SELL. 12-month probability-weighted target $57 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

SOLSEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -26.4%
Equity Research

International Flavors & Fragrances Inc (IFF)

SELL. 12-month probability-weighted target $75 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

IFFEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.7%
Equity Research

LyondellBasell Industries NV (LYB)

SELL. 12-month probability-weighted target $58 (-10% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

LYBEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -35.4%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed